Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06896435 · ClinicalTrials.gov registry record · NA
Smart-Phone Safety Behavior Fading Intervention for Appearance Concerns (Open ARSB Study)
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 401
- Enrollment target
NCT06896435: Completed NA study, sponsored by Florida State University.
NCT06896435 is a NA study that has completed, run by Florida State University. The registered enrollment target is 401 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06896435, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 401 participants
- Enrollment target
Study Summary
The current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a relaxing video intervention for appearance concerns.
Primary Outcome
Self-report scale that measures appearance anxiety symptoms. Scores range from 16 to 80 with higher scores indicating higher levels of appearance concerns.
Interventions
- BEHAVIORAL Safety Behavior Fading for Appearance Concerns
- BEHAVIORAL Relaxing Video
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 401 participants |
| Start Date | 2025-04-15 |
| Est. Completion | 2025-09-08 |
| Phase | NA |
What the finished NCT06896435 record still lists
NCT06896435 is an interventional study that assigns participants to a tested intervention. The registered 401 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (71% lower).
The record links to 0 conditions, and to 2 interventions - of which Safety Behavior Fading for Appearance Concerns is the first listed.
NCT06896435 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06896435 about?
NCT06896435 is a clinical study titled "Smart-Phone Safety Behavior Fading Intervention for Appearance Concerns (Open ARSB Study)". The current study aims to explore the efficacy of a text message based safety behavior fading intervention compared to a relaxing video intervention for appearance concerns.
What is the current status of trial NCT06896435?
This trial is currently completed. It is a NA study. The enrollment target is 401 participants. The study started on 2025-04-15. Estimated completion is 2025-09-08.
What interventions are being tested in trial NCT06896435?
The interventions under investigation include: Safety Behavior Fading for Appearance Concerns (BEHAVIORAL), Relaxing Video (BEHAVIORAL).
Who is sponsoring clinical trial NCT06896435?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06896435's enrollment target sits among peer trials
401 246th of 2000 higher than 1,755 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04464226 · 402 participants · Phase 3
Study to Continue Treatment With Darolutamide in Patients Who Have Been Participating in Previous Darolutamide Studies Supported by Bayer
- NCT05183763 · 402 participants · NA
Medication Adherence Program
- NCT06748222 · 402 participants · Phase 3
E-Mindfulness Approaches for Living After Breast Cancer
- NCT06896474 · 402 participants · NA
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI